Involvement of MEK-mitogen-activated protein kinase pathway in follicle-stimulating hormone-induced but not spontaneous meiotic resumption of mouse oocytes
Yq. Su et al., Involvement of MEK-mitogen-activated protein kinase pathway in follicle-stimulating hormone-induced but not spontaneous meiotic resumption of mouse oocytes, BIOL REPROD, 65(2), 2001, pp. 358-365
Mitogen-activated protein (MAP) kinase has been reported to be activated du
ring oocyte meiotic maturation in a variety of mammalian species. However,
the mechanism(s) responsible for MAP kinase activation and the consequence
of its premature activation during gonadotropin-induced oocyte meiotic resu
mption have not been examined. The present experiments were conducted to in
vestigate the possible role of MAP kinase in FSH-induced and spontaneous oo
cyte meiotic resumption in the mouse. MAP kinase kinase (MAPKK, MEK) inhibi
tor, PD98059 or U0126, produced a dose-dependent inhibitory effect on both
FSH-induced oocyte meiotic resumption and MAP kinase activation in the oocy
tes. However, the same inhibitor did not block spontaneous meiotic resumpti
on of either denuded or cumulus cell-enclosed mouse oocytes, despite the ac
tivity of MAP kinase being totally inhibited. Immunoblotting the oocytes an
d the cumulus cells with the anti-active MAP kinase antibody showed that MA
P kinase activity in the oocytes was detected at 8 h of FSH treatment, prio
r to germinal vesicle breakdown and increased as maturation progressed in t
he following culture period. In the cumulus cells, MAP kinase was activated
even faster, its activity was detected at I h of FSH stimulation and incre
ased gradually until 8 h of FSH treatment, then decreased and diminished af
ter 12 h of FSH action. These data demonstrated that the MEK-MAP kinase pat
hway is implicated in FSH-induced but not spontaneous oocyte meiotic resump
tion.